Background Preoperative α-fetoprotein (AFP) level levels may help select patients with
hepatocellular carcinoma (HCC) for surgery. The objective of the current study was to …

Background Serum alpha-fetoprotein (AFP) is frequently used to predict posthepatectomy
outcomes in patients with hepatocellular carcinoma (HCC), but its predictive value is still not …

Background This study aimed to investigate the role of the alpha fetoprotein (AFP) ratio
before and after curative resection in the prognosis of patients with hepatocellular carcinoma …

Alpha-fetoprotein (AFP) represents the most important biomarker for hepatocellular
carcinoma (HCC). The aim of this study was to identify the optimal staging system to predict …

Introduction Although preoperative α-fetoprotein (AFP) has been recognized as an important
tumor marker among patients with hepatocellular carcinoma (HCC), the predictive value of …

Background The value of alpha-fetoprotein (AFP) as a prognostic indicator in patients with
hepatocellular carcinoma (HCC) has been proposed in recent studies, but the evidence so …

Background Assessing the outcomes of surgeries for hepatocellular carcinoma (HCC)
patients who exceed the Milan criteria is necessary. Some studies have demonstrated that …

Background To develop and validate nomograms that can be used to predict outcomes in
individuals suffering alpha‐fetoprotein (AFP) negative hepatocellular carcinoma (HCC) after …

Background There is currently no established model for predicting the recurrence of
hepatocellular carcinoma (HCC) in patients with negative alpha‐fetoprotein (AFP) after …

AIMS: Alpha-fetoprotein (AFP) loses its potentials in treatment evaluation and prognosis
prediction in patients with AFP negative (≤ 20 ng/ml) hepatocellular carcinoma (HCC). The …